KDA Group (Pharmaceutical Products) Overview

  • Founded
  • 2009
  • Status
  • Public
  • Employees
  • 100
  • Stock Symbol
  • KDA
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $0.14
  • (As of Tuesday Closing)

KDA Group (Pharmaceutical Products) General Information


KDA Group Inc provides solutions and services to the Canadian pharmaceutical market. The company's operating segments include Pharmacy Services; Pharmaceutical Solutions; Pharmaceutical cannabis and Corporate and others. It generates maximum revenue from the Pharmacy Services segment.

Contact Information

Formerly Known As
Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Healthcare Services
Other Industries
Human Capital Services
Stock Exchange
Primary Office
  • 1351, Notre-Dame Street East
  • Suite 300
  • Thetford Mines, Quebec G6G 0G5
  • Canada
+1 (514) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KDA Group (Pharmaceutical Products) Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.14 $0.14 $0.04 - $0.18 $17.9M 126M 62.4K -$0.01

KDA Group (Pharmaceutical Products) Financials Summary

In Thousands,
TTM 31-Oct-2020 FY 2020 31-Jul-2020 FY 2019 31-Jul-2019 FY 2018 31-Jul-2018
EV 23,283 22,295
Revenue 16,860 17,002 17,441 16,026
EBITDA (1,103) (1,088) (4,394) 1,730
Net Income (1,273) (3,201) (6,432) (4,097)
Total Assets 15,248 14,845 12,233 19,157
Total Debt 5,928 6,446 7,049 12,486
Public Fundamental Data provided by Morningstar, Inc. disclaimer

KDA Group (Pharmaceutical Products) Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KDA Group (Pharmaceutical Products)‘s full profile, request access.

Request a free trial

KDA Group (Pharmaceutical Products) Executive Team (6)

Name Title Board Seat Contact Info
Sylvain Duvernay Chief Executive Officer
Pierre Monet Chief Financial Officer, Finance & Secretary, Administration
Isabelle Bégin Executive Vice President & Board Member
Jean Robert Head, Operations
You’re viewing 4 of 6 executive team members. Get the full list »

KDA Group (Pharmaceutical Products) Board Members (3)

Name Representing Role Since
00000000 0é000 KDA Group (Pharmaceutical Products) Executive Vice President & Board Member 000 0000
0000 0000000 KDA Group (Pharmaceutical Products) Chairman & Board Member 000 0000
0000000 000000 Self Board Member 000 0000
To view KDA Group (Pharmaceutical Products)’s complete board members history, request access »

KDA Group (Pharmaceutical Products) Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KDA Group (Pharmaceutical Products) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore KDA Group (Pharmaceutical Products)‘s full profile, request access.

Request a free trial

KDA Group (Pharmaceutical Products) Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 00000 29-Oct-2018 000000000000000000 Drug Discovery 0000 0000000
000000000 23-Aug-2016 000000000000000000 000.00 Pharmaceuticals 0000 0000000
000000 0.0.0. 04-Jul-2016 000000000000000000 000 Other Commercial Services 0000 0000000
000-0-000000 29-Jun-2016 000000000000000000 Human Capital Services 0000 0000000
Elitis Pharma 01-Jun-2015 Merger/Acquisition 00.000 Enterprise Systems (Healthcare) 0000 0000000
You’re viewing 5 of 6 acquisitions. Get the full list »

KDA Group (Pharmaceutical Products) Subsidiaries (4)

Company Name Industry Location Founded
Elitis Pharma Enterprise Systems (Healthcare) Varennes, Canada 2004
000000000 Pharmaceuticals Mont-Royal, Canada 0000
00000000 00000 Drug Discovery Canada
000000 0.0.0. Other Commercial Services Sainte-Julie, Canada
To view KDA Group (Pharmaceutical Products)’s complete subsidiaries history, request access »